# geneplanet d.o.o.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/geneplanet-d-o-o

- Industry: Biotechnology
- Headquarters: Ljubljana, Slovenia
- Website: www.geneplanet.com
- Total disclosed funding: $22M
- Latest round: Series B (Jul 13, 2023)
- Investors on record: 5

## About

Founded in 2008 and based in Ljubljana, Slovenia, genEplanet d.o.o., also known as GenePlanet, operates as a biotechnology company that engages in developing tests for genetic therapeutics. The company was founded by its CEO, Marko Bitenc, and Nina Šterk. In July 2026, geneplanet d.o.o. raised an undisclosed amount of venture funding from Lauxera Capital Partners.

GenePlanet provides healthcare and lifestyle solutions, mainly genetic testing solutions, cancer screening, lifestyle DNA tests, employee benefits, and corporate wellness solutions for insurance companies and corporations. The company also provides home DNA tests, medical DNA tests, blood tests, MyHeart blood tests, MyAncestry DNA tests, and Microbiome tests, which users can buy from its e-commerce platform. In addition, the company offers a mobile application for both Android and iOS users.

The company generates revenue by offering its services on a subscription-based pricing plan. The plans include premium (EUR 449), MyLifestyle (EUR 299), and MYHealth (EUR 299).

The company will use the July 2026 funding to accelerate global expansion, broaden its genetic testing portfolio, pursue acquisitions, and support regulatory approvals and market access in new territories.

## Funding rounds

- Series B, Jul 13, 2023, $22M — BlackPeak Capital, Fidelity Management and Research Company, Kolektor Ventures, Darwin AG, Designed Impact Ventures

## Investors

- BlackPeak Capital (https://capitalatlas.ai/funds/blackpeak-capital) — Series B
- Fidelity Management and Research Company — Series B
- Kolektor Ventures (https://capitalatlas.ai/funds/kolektor-ventures) — Series B
- Darwin AG — Series B
- Designed Impact Ventures — Series B